Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 18:49:33 - browse：891

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： House panel takes first step toward fixing drug shortages

WSS

FDA scientists endorse Pfizer/BioNTech Covid

Group behind ProMed defends move to subscription

Pharma showers House GOP doctor with campaign cash

The unintended consequences of overturning Roe v. Wade

'Null' research findings aren't empty of meaning. Let's publish them

How to ethically and practically extend health care to all

focus

Wikipedia

Wikipedia

At least 13 dead in Texas as scorching temps continue

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Trump demands the U.S. pay no more for drugs than other countries … again

David Liu startup to focus on CRISPR delivery

At least 13 dead in Texas as scorching temps continue

David Liu startup to focus on CRISPR delivery

State Dept. review finds Biden bears some blame for Afghanistan failures

How I helped Pfizer think through the ethics of Viagra

Apple is now the first public company to be valued at $3 trillion

H.R. 3 is the wrong path to lower drug costs

focus

FDA scientists endorse Pfizer/BioNTech Covid

FDA panel to weigh safety of artificial wombs for preterm births

Medicare slashes safety net hospital payments by nearly $1 billion

Midwives could help bridge maternal health disparities in the U.S.

FDA approves Sage Therapeutics’ rapid

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

focus

focus

hotspot

Wikipedia